Novoprotein Scientific Says AI-Enabling High-Throughput Wet Lab and Data Package Services Still in Early Market Development Stage

Stock News

Oct 07

Novoprotein Scientific Inc. (688137.SH) has issued a risk warning announcement regarding severe abnormal fluctuations in its stock trading, according to the company.

The company disclosed that revenue from RNA vaccine drug-related products in 2025 accounted for 11.38% of total product revenue, representing a relatively low proportion.

Its AI-enabling high-throughput wet lab and data package services remain in the early stage of market development, with related business revenue accounting for less than 2% of the company's total operating revenue as of the first half of 2026.

Given that the application of AI in the pharmaceutical R&D industry is still in its infancy, there are risks including rapid technological iteration, lengthy industry validation cycles, and significant difficulties in commercial implementation.

The company's future revenue and profit realization from related businesses face substantial uncertainty.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1195371302"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1195371302\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1195371302?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-07 16:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1195371302","market":"other","top_or_hot":-1,"title":"Novoprotein Scientific Says AI-Enabling High-Throughput Wet Lab and Data Package Services Still in Early Market Development Stage","media":"Stock News","content":"<p><b>Novoprotein Scientific Inc.</b> (<b>688137.SH</b>) has issued a risk warning announcement regarding severe abnormal fluctuations in its stock trading, according to the company.<br><br>The company disclosed that revenue from RNA vaccine drug-related products in 2025 accounted for 11.38% of total product revenue, representing a relatively low proportion.<br><br>Its AI-enabling high-throughput wet lab and data package services remain in the early stage of market development, with related business revenue accounting for less than 2% of the company's total operating revenue as of the first half of 2026.<br><br>Given that the application of AI in the pharmaceutical R&D industry is still in its infancy, there are risks including rapid technological iteration, lengthy industry validation cycles, and significant difficulties in commercial implementation.<br><br>The company's future revenue and profit realization from related businesses face substantial uncertainty.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novoprotein Scientific Says AI-Enabling High-Throughput Wet Lab and Data Package Services Still in Early Market Development Stage</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovoprotein Scientific Says AI-Enabling High-Throughput Wet Lab and Data Package Services Still in Early Market Development Stage\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-10-07 16:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Novoprotein Scientific Inc.</b> (<b>688137.SH</b>) has issued a risk warning announcement regarding severe abnormal fluctuations in its stock trading, according to the company.<br><br>The company disclosed that revenue from RNA vaccine drug-related products in 2025 accounted for 11.38% of total product revenue, representing a relatively low proportion.<br><br>Its AI-enabling high-throughput wet lab and data package services remain in the early stage of market development, with related business revenue accounting for less than 2% of the company's total operating revenue as of the first half of 2026.<br><br>Given that the application of AI in the pharmaceutical R&D industry is still in its infancy, there are risks including rapid technological iteration, lengthy industry validation cycles, and significant difficulties in commercial implementation.<br><br>The company's future revenue and profit realization from related businesses face substantial uncertainty.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ARTY","symbol_name":"ISHARES FUTURE AI & TECH ETF","start_time":0,"source_url":"","article_id":"1195371302","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1195371302","pubTimestamp":1791360024,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Novoprotein Scientific Inc. (688137.SH) has issued a risk warning announcement regarding severe abnormal fluctuations in its stock trading, according to the company.The company disclosed that revenue...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688137":"近岸蛋白","ARTY":"ISHARES FUTURE AI & TECH ETF","QTOC":"Innovator Growth Accelerated Plus ETF - October","BK0216":"研究试验","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","VTHR":"Vanguard Russell 3000 ETF","AIPO":"Defiance AI and Power Infrastructure ETF","AGIX":"通用人工智能 ETF-AGIX"},"translate_title":"Novoprotein Scientific 表示支持人工智能的高通量湿实验室和数据包服务仍处于早期市场开发阶段","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688137":1,"AIPO":1,"CHAT":1,"ARTY":1,"QTOC":1,"AGIX":1,"VTHR":1},"content_text":"Novoprotein Scientific Inc. (688137.SH) has issued a risk warning announcement regarding severe abnormal fluctuations in its stock trading, according to the company.The company disclosed that revenue from RNA vaccine drug-related products in 2025 accounted for 11.38% of total product revenue, representing a relatively low proportion.Its AI-enabling high-throughput wet lab and data package services remain in the early stage of market development, with related business revenue accounting for less than 2% of the company's total operating revenue as of the first half of 2026.Given that the application of AI in the pharmaceutical R&D industry is still in its infancy, there are risks including rapid technological iteration, lengthy industry validation cycles, and significant difficulties in commercial implementation.The company's future revenue and profit realization from related businesses face substantial uncertainty.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}